{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:09:18Z","timestamp":1768414158352,"version":"3.49.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery Case Reports"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ijscr.2021.106047","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T20:16:55Z","timestamp":1622319415000},"page":"106047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Combined modality therapy including cytoreductive surgery and heated intraperitoneal chemotherapy for synchronous low volume peritoneal carcinomatosis from adenocarcinoma of the tail of pancreas in a BRCA-2 carrier resulting in long-term disease-free survival: A case report"],"prefix":"10.1097","volume":"83","author":[{"given":"Richard A.","family":"Hoefer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chukwuemeka","family":"Obiora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basem","family":"Azab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Harden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijscr.2021.106047_bb0005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","article-title":"The SCARE 2020 guideline: updating consensus Surgical Case Report (SCARE) guidelines","volume":"84","author":"Agha","year":"2020","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijscr.2021.106047_bb0010","unstructured":"National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Pancreatic Cancer Screening (version 2.2021)."},{"key":"10.1016\/j.ijscr.2021.106047_bb0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/jso.25376","article-title":"Are BRCA1 and BRCA2 gene mutation patients under screened for pancreatic adenocarcinoma?","volume":"119","author":"Roch","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.ijscr.2021.106047_bb0020","doi-asserted-by":"crossref","DOI":"10.1200\/PO.19.00115","article-title":"Outcomes in patients with pancreatic adenocarcinoma with genetic mutations in DNA damage response pathways: results from the know your tumor program","author":"Pishvaian","year":"2019","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.ijscr.2021.106047_bb0025","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/CAD.0000000000000178","article-title":"Clinical outcomes in pancreatic adenocarcinoma associated with BRCA-2 mutation","volume":"26","author":"Vyas","year":"2015","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.ijscr.2021.106047_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2821-0","article-title":"Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer \u2013 a case report and review","volume":"16","author":"Gostimir","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijscr.2021.106047_bb0035","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00432-018-2666-9","article-title":"Emerging strategies in BRCA-positive pancreatic cancer","volume":"144","author":"Kawalewski","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ijscr.2021.106047_bb0040","first-page":"40","article-title":"A case report of a dramatic response to Olaparib in a patient with metastatic pancreatic cancer harboring a germline BRCA2 mutation","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine."},{"key":"10.1016\/j.ijscr.2021.106047_bb0045","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/1354750X.2020.1725786","article-title":"Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis","volume":"25","author":"Van Manen","year":"2020","journal-title":"BIOMARKERS."},{"key":"10.1016\/j.ijscr.2021.106047_bb0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jamcollsurg.2016.02.009","article-title":"Carbohydrate antigen 19-9 elevation in anatomically resectable, early-stage pancreatic cancer is independently associated with decreased overall survival and an indication for neoadjuvant therapy: a National Cancer Database Study","volume":"223","author":"Bergquist","year":"2016","journal-title":"J. Am. Coll. Surg."},{"issue":"18","key":"10.1016\/j.ijscr.2021.106047_bb0055","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1200\/JCO.2005.05.3934","article-title":"Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma","volume":"24","author":"Ferrone","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijscr.2021.106047_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.hpb.2015.10.004","article-title":"Indications for staging laparoscopy in pancreatic cancer","volume":"8","author":"DeRosa","year":"2016","journal-title":"HPB."},{"key":"10.1016\/j.ijscr.2021.106047_bb0065","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.gassur.2006.07.013","article-title":"The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma","volume":"10","author":"Ferrone","year":"2006","journal-title":"J. Gastrointest. Surg."},{"issue":"2","key":"10.1016\/j.ijscr.2021.106047_bb0070","first-page":"482","article-title":"Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer","volume":"23","author":"Tentes","year":"2018","journal-title":"JBUON."},{"issue":"8","key":"10.1016\/j.ijscr.2021.106047_bb0075","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/02656736.2016.1227094","article-title":"The effect of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) as an adjuvant in patients with resectable pancreatic cancer","volume":"32","author":"Tentes","year":"2016","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.ijscr.2021.106047_bb0080","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.3390\/ijms14024163","article-title":"Brain metastases in pancreatic cancer","volume":"14","author":"Lemke","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijscr.2021.106047_bb0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1245\/s10434-018-6992-6","article-title":"Morbidity and mortality following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: data from the DGAV StuDoQ registry with 2149 consecutive patients","volume":"26","author":"Piso","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ijscr.2021.106047_bb0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/SLA.0000000000001225","article-title":"Is the combination of distal pancreatectomy and cytoreductive surgery with HIPEC reasonable?","volume":"263","author":"Schwarz","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ijscr.2021.106047_bb0095","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1245\/s10434-014-4186-4","article-title":"A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion","volume":"22","author":"Downs-Canner","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ijscr.2021.106047_bb0100","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","article-title":"The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after","volume":"161","author":"Bassi","year":"2017","journal-title":"Surgery."}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261221005496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261221005496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:37:08Z","timestamp":1768387028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210261221005496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":20,"alternative-id":["S2210261221005496"],"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2021.106047","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined modality therapy including cytoreductive surgery and heated intraperitoneal chemotherapy for synchronous low volume peritoneal carcinomatosis from adenocarcinoma of the tail of pancreas in a BRCA-2 carrier resulting in long-term disease-free survival: A case report","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijscr.2021.106047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106047"}}